Search Menu
Photonics Media Photonics Marketplace Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook

BioLight 2015 Revenue

Facebook Twitter LinkedIn Email Comments
TEL AVIV, Israel, April 5, 2016 — BioLight Life Sciences Ltd., a publically traded ophthalmic technology development firm, has reported its 2015 financial results and said it has achieved all previously announced 2015 milestones.

For the fiscal year ended Dec. 31, 2015, the company reported revenues of New Israeli Shekels (NIS) 1.4 million (about $360,000) from sales of its IOPtiMate System, a laser-based noninvasive surgical treatment for glaucoma.

Net loss for 2015 was approximately NIS 27.6 million ($7.1 million), or NIS 7.98 loss per share, compared to a net loss of approximately NIS 36 million ($9.2 million), or NIS 11.96 loss per share, for 2014. At the close of fiscal 2015, the company had approximately NIS 51 million ($13.1 million) in cash and short-term deposits.
Apr 2016
The branch of medicine involved in the study of the anatomy, functions, diseases and treatments of the eye.

view all
Search more than 4000 manufacturers and suppliers of photonics products and services worldwide:

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2021 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, [email protected]

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.